Article
Hydrocodone in postoperative personalized pain management: pro-drug or drug?
Clinica chimica acta; international journal of clinical chemistry - 15 Feb 2014
Stauble M Elaine, Moore Andrew W, Langman Loralie J, Boswell Mark V, Baumgartner Richard, McGee Suzanne, Metry Jonathan, Jortani Saeed A
Abstract excerpt
BACKGROUND: Genetic variations in enzymes that produce active metabolites from pro-drugs are well known. Such variability could account for some of the clinically observed differences in analgesia and side effects seen in postoperative patients. Using genotyping and quantitation of serum concentrations of hydrocodone and its metabolites, we sought to demonstrate the clinical effects of the metabolites of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
